Patient-derived melanoma organoid models facilitate the assessment of immunotherapies is a research paper published in EBioMedicine (2023). On theSindex it has a DataRank of 0.675. It has been cited 89 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.675
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: CA114046
National Institutes of Health
Grant: CA258113
National Institutes of Health
Grant: CA261608
National Institutes of Health
Grant: 2P01CA114046-11A1
Targeted Therapies in Melanoma
National Institutes of Health
Grant: 1P50CA261608-01
SPORE in Skin Cancer
National Institutes of Health
Grant: 3R01CA258113-02S1
Explore Gamma delta T cell-based glioblastoma therapies
Fields of Study
Keywords